Effect of different inactivants and preservatives on the stability of 146S fraction of foot-and-mouth diseases virus

Document Type : Original Article

Authors

1 Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan

2 Department of Biotechnology, Lahore College for Woman University, Lahore, Pakistan

Abstract
Foot-and-mouth disease virus (FMDV) cripples livestock by imparting devastating effects to economy. A good vaccine is the key to stopping it, but due to instability of 146S of FMDV, it is becoming difficult. This is bad because only 146S can fight against disease and its dissociation ultimately leads to decreased potency of vaccine. This study aimed to preserve the integrity of 146S in vaccine using different inactivators and preservatives. Foot-and-mouth Disease virus type ‘O’ was propagated on baby hamster kidney 21 cell lines and inactivated using formalin or binary ethylenimine (BEI). Size exclusion high performance liquid chromatography analysis revealed minimal 146S loss after double inactivation with formalin and BEI. This inactivated virus was further formulated into oil-based vaccine with sodium thiomersal or chloroform as a preservative. Our findings demonstrated that chloroform outperformed thiomersal in maintaining shelf life of vaccine. This claims that the combined approach of double inactivation with formalin and BEI followed by chloroform as preservative offered a promising strategy for developing efficacious FMDV.

Keywords

Subjects


  1. Soliman EM, Mahdy SE, Mossad WG, et al. Effect of different inactivators on the efficacy of Egyptian food-and-mouth disease SAT2 vaccine. J Anim Sci Adv 2013; 3(8): 392-399.
  2. Harmsen MM, Seago J, Perez E, et al. Isolation of single-domain antibody fragments that preferentially detect intact (146S) particles of foot-and-mouth disease virus for use in vaccine quality control. Front immunol 2017; 8: 960. doi: 10.3389/fimmu.2017.00960.
  3. Martín-Acebes MA, Vázquez-Calvo Á, González-Magaldi M, et al. Foot-and-mouth disease virus particles inactivated with binary ethylenimine are efficiently internalized into cultured cells. Vaccine 2011; 29(52): 9655-9662.
  4. Rweyemamu MM, Unehara O, Giorgi W, et al. Effect of formaldehyde and binary ethyleneimine (BEI) on the integrity of foot-and-mouth disease virus capsid. Rev Sci Tech 1989; 8(3): 747-764.
  5. Sharma GK, Mahajan S, Matura R, et al. Diagnostic assays developed for the control of foot-and-mouth disease in India. World J Virol 2015; 4(3): 295-302.
  6. Caridi F, Vázquez-Calvo A, Sobrino F, et al. The pH stability of foot-and-mouth disease virus particles is modulated by residues located at the pentameric interface and in the N terminus of VP1. J Virol 2015; 89(10): 5633-5642.
  7. Feng X, Ma JW, Sun SQ, et al. Quantitative detection of the foot-and-mouth disease virus serotype O 146S antigen for vaccine production using a double-antibody sandwich ELISA and nonlinear standard curves. PloS One 2016; 11(3): e0149569. doi: 10.1371/journal. pone.0149569.
  8. Lee SY, Lee YJ, Kim RH, et al. Rapid engineering of foot-and-mouth disease vaccine and challenge viruses. J Virol 2017; 91(16): e00155-17. doi: 10.1128/ JVI.00155-17.
  9. Facciolà A, Visalli G, Laganà A, et al. An overview of vaccine adjuvants: current evidence and future perspectives. Vaccines (Basel) 2022; 10(5): 819. doi: 10.3390/vaccines10050819.
  10. Zeng L, Wang MD, Ming SL, et al. An effective inactivant based on singlet oxygen-mediated lipid oxidation implicates a new paradigm for broad-spectrum antivirals. Redox Biol 2020; 36: 101601. doi: 10.1016/ j.redox.2020.101601.
  11. Mohamed AA, Mosad W, Gamil MA, et al. Using chloroform as a preservative for trivalent food-and-mouth disease vaccine in comparison to thiomersal. Arab Univ J Agric Sci 2019; 2(3): 61-78.
  12. Rahman S, Rabbani M, Muhammad SK, et al. Studies on in vitro culture characteristics of adherent baby Hamster Kidney-21 (BHK-21) cell line. Int J Agric Biol 2007; 9(6): 821-826
  13. Amadori M, Volpe G, Defilippi P, et al. Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine. Biologicals 1997; 25(1): 65-73.
  14. Nadgir SV, Hensler HR, Knowlton ER, et al. Fifty percent tissue culture infective dose assay for determining the titer of infectious human herpesvirus 8. J Clin Microbiol 2013; 51(6): 1931-1934.
  15. AAT Bioquest I. Quest CalculateTM PBS (Phosphate Buffered Saline) (1X, pH 7.4) preparation and recipe. Available at: https://www.aatbio.com/resources/buffer-preparations-and-recipes/pbs-phosphate-buffered-sali ne. Accessed May 12, 2024.
  16. Yang Y, Li H, Li Z, et al. Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens. Vaccine 2015; 33(9): 1143-1150.
  17. Shirai J, Chatchawanchonteera A, Sinsuwongwat W, et al. Estimation of 140S particles in foot-and-mouth disease virus (FMDV) vaccine by using the computer analyzing system. Nihon Juigaku Zasshi 1990; 52(3): 621-630.
  18. Bahnemann H. Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol 1975; 47(1): 47-56.
  19. Ismail HA, El-Mahdy SA, Mossad WG, et al. Optimization of the inactivation process of FMD virus serotype SAT-2 by binary ethyleneimine (BEI). J Vet Adv 2013; 3(3): 117-124.
  20. Barteling SJ, Cassim NI. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde. Dev Biol (Basel) 2004; 119: 449-455.
  21. Salk JE, Krech U, Youngner J, et al. Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines. Am J Public Health Nations Health 1954; 44(5): 563-570.
  22. Park JH. Requirements for improved vaccines against foot-and-mouth disease epidemics. Clin Exp Vaccine Res 2013; 2(1): 8-18.
  23. Mahmud MS, Islam E, Giasuddin M, et al. Biological assay of food-and-mouth disease virus (FMDV) serotypes for titrating BLRI developed trivalent FMD vaccines seed. Immunol Infect Dis 2018; 6(2): 23-26.
  24. Motamedi-Sedeh F, Soleimanjahi H, Jalilian AR, et al. Development of protective immunity against inactivated Iranian isolate of foot-and-mouth disease virus type O/IRN/2007 using gamma ray-irradiated vaccine on BALB/c mice and Guinea pigs. Intervirology 2015; 58(3): 190-196.
  25. Li H, Yang Y, Zhang Y, et al. A hydrophobic interaction chromatography strategy for purification of inactivated foot-and-mouth disease virus. Protein Expr Purif 2015; 113: 23-29.
  26. Rowlands DJ, Sangar DV, Brown F. Stabilizing the immunizing antigen of foot-and-mouth disease virus by fixation with formaldehyde. Arch Gesamte Virusforsch 1972; 39(1): 274-283.
  27. Bahnemann HG. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 1990; 8(4): 299-303.
  28. Mowat GN, Masters RC, Prince MJ. Enhancement of immunizing potency of a foot-and-mouth disease vaccine for cattle by treatment of the antigen with formaldehyde. Arch Gesamte Virusforsch 1973; 41(4): 365-370.
  29. Harmsen MM, Fijten HP, Westra DF, et al. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles. Vaccine 2011; 29(15): 2682-2690.
Volume 15, Issue 7
July 2024
Pages 351-356

  • Receive Date 15 June 2023
  • Revise Date 11 January 2024
  • Accept Date 04 March 2024